Status:

RECRUITING

Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse

Lead Sponsor:

University of North Carolina, Chapel Hill

Conditions:

Opioid Use

Surgical Recovery

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

The goal of the study to see if giving a numbing medicine around the cervix (called a paracervical block) during vaginal hysterectomy with prolapse repair helps people feel less pain and need fewer st...

Detailed Description

Secondary outcomes are to: 1. Compare postoperative pain scores in patients undergoing vaginal hysterectomy for prolapse repair who receive an intraoperative paracervical block compared to placebo 2....

Eligibility Criteria

Inclusion

  • Individuals undergoing vaginal hysterectomy with concomitant prolapse repair procedure

Exclusion

  • Non-English speaking
  • Weight less than 50 kg
  • Allergy to bupivacaine
  • Pregnant

Key Trial Info

Start Date :

October 20 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT07213635

Start Date

October 20 2025

End Date

December 1 2026

Last Update

October 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina Urogynecology and Reconstructive Pelvic Surgery at REX

Raleigh, North Carolina, United States, 27607